# Long-Term Outcomes of Selexipag in Schistosomiasis-Associated Pulmonary Arterial Hypertension

> **NCT07453030** · — · NOT_YET_RECRUITING · sponsor: **Caio Júlio César dos Santos Fernandes** · enrollment: 30 (estimated)

## Conditions studied

- Pulmonary Arterial Hypertension (PAH)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07453030
- **Lead sponsor:** Caio Júlio César dos Santos Fernandes
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2027-03-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07453030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07453030, "Long-Term Outcomes of Selexipag in Schistosomiasis-Associated Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07453030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*